ProgramsFujita Health UniversityDevelopment of Triple Translation Initiation Site (AUG) Antisense Oligonucleotide as a Therapeutic Agent for Neurodegenerative Diseases
postgraduate
Development of Triple Translation Initiation Site (AUG) Antisense Oligonucleotide as a Therapeutic Agent for Neurodegenerative Diseases
Fujita Health University
Japan
Language
English
About this program
Research into the development of triple translation initiation site (AUG) antisense oligonucleotide as a therapeutic agent for neurodegenerative diseases.
Program highlights
Teaching Language
English
Tuition fee
Contact for feeSave to favorites
Apply Now
Development of Triple Translation Initiation Site (AUG) Antisense Oligonucleotide as a Therapeutic Agent for Neurodegenerative Diseases